| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.73 | 0.005 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |